4.9.2023 |
EN |
Official Journal of the European Union |
C 314/16 |
Action brought on 14 July 2023 — Stada Arzneimittel v EUIPO — Bioiberica (DAOgest)
(Case T-396/23)
(2023/C 314/20)
Language in which the application was lodged: English
Parties
Applicant: Stada Arzneimittel AG (Bad Vilbel, Germany) (represented by: J.-C. Plate, R. Kaase and K. Schmid-Burgk, lawyers)
Defendant: European Union Intellectual Property Office
Other party to the proceedings before the Board of Appeal: Bioiberica, SAU (Palafolls, Spain)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Other party to the proceedings before the Board of Appeal
Trade mark at issue: Application for European Union word mark DAOgest — Application for registration No 18 332 942
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Second Board of Appeal of EUIPO of 25 April 2023 in Case R 1384/2022-2
Form of order sought
The applicant claims that the Court should:
— |
annul the contested decision; |
— |
order EUIPO to pay the costs of the proceedings. |
Pleas in law
— |
Infringement of Article 94(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |
— |
Infringement of Article 95(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |
— |
Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |